olmesartan medoxomil has been researched along with omega-n-methylarginine in 1 studies
| Studies (olmesartan medoxomil) | Trials (olmesartan medoxomil) | Recent Studies (post-2010) (olmesartan medoxomil) | Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) |
|---|---|---|---|---|---|
| 459 | 119 | 203 | 4,411 | 344 | 336 |
| Protein | Taxonomy | olmesartan medoxomil (IC50) | omega-n-methylarginine (IC50) |
|---|---|---|---|
| Neutrophil elastase | Homo sapiens (human) | 0.3 | |
| Proteinase-activated receptor 1 | Homo sapiens (human) | 0.0018 | |
| Nitric oxide synthase, endothelial | Bos taurus (cattle) | 7 | |
| Nitric oxide synthase, endothelial | Homo sapiens (human) | 2.9489 | |
| Nitric oxide synthase, brain | Homo sapiens (human) | 3.3983 | |
| Nitric oxide synthase, brain | Rattus norvegicus (Norway rat) | 7.5 | |
| Nitric oxide synthase, inducible | Mus musculus (house mouse) | 2.3 | |
| Nitric oxide synthase, inducible | Homo sapiens (human) | 2.9252 | |
| Collagenase 3 | Homo sapiens (human) | 0.3 | |
| Nitric oxide synthase, brain | Mus musculus (house mouse) | 4.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashida, Y; Morishita, T; Nakashima, Y; Nakata, S; Sasaguri, Y; Suda, O; Tasaki, H; Toyohira, Y; Tsujimoto, T; Tsutsui, M; Ueno, S; Ueta, Y; Yanagihara, N | 1 |
1 other study(ies) available for olmesartan medoxomil and omega-n-methylarginine
| Article | Year |
|---|---|
Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Coronary Disease; Enzyme Induction; Homocysteine; Imidazoles; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Myocardium; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Olmesartan Medoxomil; omega-N-Methylarginine; Oxidative Stress; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Superoxides; Tetrazoles; Thiazepines | 2004 |